Ocrelizumab in Early-Stage Relapsing-Remitting Multiple Sclerosis: The Phase IIIb ENSEMBLE 4-Year, Single-Arm, Open-Label Trial
奥克瑞珠单抗治疗早期复发缓解型多发性硬化症：IIIb期ENSEMBLE 4年单臂开放标签试验
期刊:Neurology
影响因子:8.5
doi:10.1212/WNL.0000000000210049
Hartung, Hans-Peter; Benedict, Ralph H B; Berger, Thomas; Bermel, Robert A; Brochet, Bruno; Carroll, William M; Freedman, Mark S; Holmøy, Trygve; Karabudak, Rana; Nos, Carlos; Patti, Francesco; Perrin Ross, Amy; Vanopdenbosch, Ludo; Vollmer, Timothy; Wuerfel, Jens; Clinch, Susanne; Kadner, Karen; Kuenzel, Thomas; Kulyk, Inessa; Raposo, Catarina; Thanei, Gian-Andrea; Killestein, Joep
